Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$6.4 - $9.85 $171,500 - $263,950
-26,797 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$6.9 - $9.9 $88,299 - $126,690
12,797 Added 91.41%
26,797 $222,000
Q1 2018

May 14, 2018

BUY
$7.2 - $10.05 $100,800 - $140,700
14,000 New
14,000 $101,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.9B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.